[Clinical evaluation of a new preparation of Ersilan drops in patients with vascular headaches].
Serclová
L
L
D000328:Adult; D002986:Clinical Trials as Topic; D004088:Dihydroergotoxine / Q000008:administration & dosage / Q000627:therapeutic use*; D004304:Dosage Forms; D004311:Double-Blind Method; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013806:Theophylline / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014653:Vascular Headaches / Q000188:drug therapy*
D004304:Dosage Forms; D004338:Drug Combinations; D004088:Dihydroergotoxine; C060255:Ersilan; D013806:Theophylline
Klinické zhodnocení nového prí'pravku Ersilan kapky u nemocných s cévními bolestmi hlavy.